IDH2 and central nervous system cancer: While in IDH wildtype glioblastoma CDKN2A deletions are nearly universally homozygous, we acknowledge that in some patients with IDH1/2mt gliomas, the CDKN2A deletion as determined by NGS may not be homozygous.